Bio Impact Capital LLC Nuvation Bio Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 4,164,178 shares of NUVB stock, worth $9.58 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
4,164,178Holding current value
$9.58 Million% of portfolio
1.66%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
163Shares Held
151MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$59.7 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$36.2 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$30.1 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$21.2 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $500M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...